A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
RasCal Therapeutics, Inc.
RasCal Therapeutics, Inc.
Orano Med LLC
Novartis
Eli Lilly and Company
BerGenBio ASA
Blueprint Medicines Corporation
ABM Therapeutics Corporation
ABM Therapeutics Corporation
Celgene
Sumitomo Pharma America, Inc.
SCRI Development Innovations, LLC
Karyopharm Therapeutics Inc
Quadriga Biosciences, Inc.
Fudan University
Novartis
Jiujiang University Affiliated Hospital
Tocagen Inc.
AbbVie
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Pfizer
Dana-Farber Cancer Institute
Case Comprehensive Cancer Center
Pharmacyclics LLC.